A team of clinical investigators at Memorial Sloan Kettering Cancer Center (MSKCC) have developed and conducted a first-in-human, Phase 1 clinical trial investigating regionally delivered,…
Haizhen (Jen) Wang, Ph.D., recently found out that her traditional R01 application for funding to the National Cancer Institute (NCI), part of the National Institutes…
Physician-scientists from the University of Chicago Medicine Comprehensive Cancer Center recently studied a vexing question associated with the pediatric fight against neuroblastoma. How do children’s immune systems…
Recent study results involving a group of patients enrolled in the Phase 2/3 QUILT-3.032 clinical trial indicate that patients whose non-muscle invasive bladder cancer (NMIBC)…
The U.S. Food and Drug Administration (FDA) first in 2017 authorized the use of a chimeric antigen receptor therapy, approving tisagenlecleucel to treat children and/or…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
